Investigating the link between omentin levels and ischemic stroke
The Association of Omentin and Ischemic Stroke
This study is trying to see if the levels of a protein called omentin in the blood are different in people who have just had an ischemic stroke compared to those who haven't had a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | Xi'an No.3 Hospital Government |
| Locations | 1 site (Xi'an, Shanxi) |
| Trial ID | NCT03125759 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between omentin, a type of adipokine, and ischemic stroke by comparing plasma omentin levels in patients with acute ischemic stroke to those without any history of stroke. The study will recruit newly diagnosed acute ischemic stroke patients and a control group to analyze differences in omentin levels and the associated gene symbol ITLN. The findings may provide insights into the role of omentin in stroke incidence, severity, and recovery.
Who should consider this trial
Good fit: Ideal candidates include individuals with newly diagnosed acute ischemic stroke and those without any prior stroke history.
Not a fit: Patients with hemorrhagic stroke or a history of previous ischemic strokes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of ischemic stroke mechanisms and potentially lead to new biomarkers for risk assessment and recovery.
How similar studies have performed: While the relationship between adipokines and stroke has been explored, this specific focus on omentin in ischemic stroke is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * For ischemic stroke group,acute clinically defined ischemic stroke * For control group, without any history of stroke Exclusion Criteria: For ischemic stroke group * Hemorrhagic Stroke * Previous Ischemic Stroke For control group * The expected life expense less than 3 years
Where this trial is running
Xi'an, Shanxi
- Xi'an No.3 Hospital — Xi'an, Shanxi, China (Recruiting)
Study contacts
- Principal investigator: Tian Ye, PhD — Xi'an No.3 Hospital
- Study coordinator: Tian Ye, PhD
- Email: chhty@sina.com
- Phone: +86 13519131549
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.